Paradigm Biopharmaceuticals has selected Advanced Clinical as the clinical research organisation (CRO) to support its pivotal ...
Paradigm Biopharmaceuticals has launched loyalty options and piggyback options offers which could potentially raise more than ...
In a report released today, John Hester from Bell Potter maintained a Buy rating on Paradigm Biopharmaceuticals Ltd. (PBIGF – Research Report), ...
Venture capital (VC) firm Paradigm has revealed plans to lend a helping hand to Tornado Cash developer Roman Storm.
Venture Capital firm Paradigm has released a blog post calling for the acceleration of Ethereum's development. The post, co-authored by executives at the ...
Paradigm by Puloliâ„¢, an IoT solutions provider specializing in affordable methane monitoring at scale, today announces the launch of its Controlled Release Testing (CRT) 2.0 site. The expanded and ...
Have updates? Send them our way! You know your company best! If there is information about your company that you’d like changed, please fill out the linked form to submit an update.
Paradigm Funds has some investor-friendly attributes, but other attributes warrant caution, leading to an Average Parent Pillar rating. Even with an average pillar rating, Paradigm Funds has had ...